Ratings eHealth, Inc.

Equities

EHTH

US28238P1093

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
4.49 ^USD	-2.60%		-7.80%	-48.51%

Apr. 18	EHealth Reaffirms 2024 Guidance	MT
Apr. 15	Adherium’s Hailie Smartinhaler Secures FDA Approval for Use with AstraZeneca's Airsupra and Breztri Inhalation Devices	MT

Strengths

The stock, which is currently worth 2024 to 0.16 times its sales, is clearly overvalued in comparison with peers.
The company appears to be poorly valued given its net asset value.
The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.

Weaknesses

The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
The company has insufficient levels of profitability.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Multiline Insurance & Brokers

	1st Jan change	Capi.	ESG Refinitiv
EHEALTH, INC.	-48.51%	133M	C-
ARTHUR J. GALLAGHER & CO.	+5.20%	51.08B	B-
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY	+9.67%	26.89B	C+
BROWN & BROWN, INC.	+15.55%	23.15B	C
CAIXA SEGURIDADE PARTICIPAÇÕES S.A.	+20.54%	8.82B	-
RYAN SPECIALTY HOLDINGS, INC.	+19.06%	5.97B	-
STEADFAST GROUP LIMITED	-5.33%	3.94B	B
AUB GROUP LIMITED	+0.14%	1.94B	C+
BRP GROUP, INC.	+14.86%	1.74B	C-
GOOSEHEAD INSURANCE, INC	-23.73%	1.43B	C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes